For the Inventor, By the Inventor

Enter assignee name

Philadelphia, PA, United States of America

Smithkline Corporation

Calculating rank

USPTO Granted Patents = 344

Trademarks = 3

Forward Citations = 2,135

Loading Chart...

Loading Chart...

140 inventors (with patents filed for the assignee):

David A Berges (52 out of 56 patents)

John G Gleason (31 out of 66 patents)

Carl Kaiser (25 out of 46 patents)

4. Joseph Weinstock (21 out of 65 patents)

5. Bernard Loev (21 out of 22 patents)

6. John R Hoover (21 out of 25 patents)

7. Robert M DeMarinis (20 out of 35 patents)

8. David T Hill (20 out of 43 patents)

9. Kenneth G Holden (20 out of 21 patents)

10. L Martin Brenner (13 out of 13 patents)

11. Kenneth M Snader (13 out of 16 patents)

12. Ivan Lantos (12 out of 19 patents)

13. Paul E Bender (11 out of 44 patents)

14. Robert G Pendleton (11 out of 11 patents)

15. Blaine M Sutton (11 out of 11 patents)

Core Competencies:

Pharmaceutical Compositions

Antiallergic Compounds

Renal Vasodilators

Dopaminergic Isoquinolines

Guanidinopyrimidines

Cephalosporins

Imidodisulfamides

Tetrahydroisoquinolines

Tetrazole Thiols

Auranofin

Antibiotics

Thiazoles

344 patents: Sort by Forward Citations

1. D917256 - Coping saw (2021-04-27),

2. 7247748 - Amide compounds and methods of using the same (2007-07-24),

3. 6331631 - Preparation of 1-butyl-4-piperidinylmethylamine (2001-12-18),

4. 4353902 - Livestock feed and method for improving food utilization (1982-10-12),

5. 4352809 - Method of producing alpha.sub.2 antagonism (1982-10-05),

6. 4352754 - 3-Thienylmethyl-6-halo-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1 (1982-10-05),

7. 4350698 - Antiallergic imidosulfamides (1982-09-21),

8. 4350685 - Antiallergic imidodisulfamides (1982-09-21),

9. 4342686 - Intermediates for preparing 6-lower (1982-08-03),

10. 4341786 - Pharmaceutical compositions and method of producing central alpha.sub.1 (1982-07-27),

11. 4340733 - Process for preparing 3-chloro-6-(2-hydroxyphenyl)-pyridazines (1982-07-20),

12. 4340601 - Dopaminergic isoquinolines (1982-07-20),

13. 4340600 - Renal dilating methods and compositions using (1982-07-20),

14. 4336255 - Pharmaceutical compositions containing guanidinopyrimidines (1982-06-22),

15. 4336254 - Guanidinopyrimidine compounds, compositions and method of using as a (1982-06-22),

Company Overview

Smithkline Corporation, headquartered in Philadelphia, PA, specializes in the development and manufacturing of pharmaceutical compositions. The company focuses on a diverse range of core technology topics, including antiallergic compounds, renal vasodilators, and various classes of compounds such as dopaminergic isoquinolines and guanidinopyrimidines. With a commitment to advancing healthcare, Smithkline plays a significant role in the pharmaceutical industry, contributing innovative solutions to address various medical needs.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

344 Patents

#9 in Philadelphia, PA

#55 in Pennsylvania

#1,312 in US

#2,647 in the World

Philadelphia, PA, United States of America

Smithkline Corporation

Forward Citations = 2,135

140 inventors:

David A Berges (52 out of 56 patents)

John G Gleason (31 out of 66 patents)

Carl Kaiser (25 out of 46 patents)

4. Joseph Weinstock (21 out of 65 patents)

5. Bernard Loev (21 out of 22 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Smithkline Corporation. Retrieved from https://idiyas.com/company/smithkline

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…